Invus Financial Advisors’s Unity Biotechnology UBX Stock Holding History

Invus Financial Advisors’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-109,500	Closed	-$1.6M	–	9
2021 Q4	$1.6M	Hold	109,500	–	–	0.49%	8
2021 Q3	$3.29M	Hold	109,500	–	–	0.88%	8
2021 Q2	$5.08M	Hold	109,500	–	–	1.01%	8
2021 Q1	$6.57M	Hold	109,500	–	–	1.51%	7
2020 Q4	$5.74M	Hold	109,500	–	–	2.4%	6
2020 Q3	$3.79M	Sell	109,500 -109,500	-50%	-$6.93M	1.82%	6
2020 Q2	$19M	Hold	219,000	–	–	6.87%	6
2020 Q1	$12.7M	Hold	219,000	–	–	6.24%	5
2019 Q4	$15.8M	Buy	+219,000	New	+$15.5M	8.01%	5

Other funds holding UBX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return